ChartRow logo
Share this page
VIR
$9.96-4.87%
as of close, Oct 16, 2026
☾ AH $9.96 -4.87%
PeersMRNALLYMDTUNHJNJTMO

VIR financial statements

The full income statement, balance sheet, and cash-flow statement for Vir Biotechnology Inc. (VIR), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 136.6M2024-09 137.7M2024-12 137.1M2025-03 138.2M2025-06 138.9M2025-09 139.1M2025-12 139.5M2026-03 168.7M2026-06 169.2M+23.8% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue68.6M-7.6%74.2M-13.9%86.2M-94.7%1.62B+47.5%1.10B+1334.4%
Cost of revenue26.0K-96.9%845K-69.4%2.77M-98.1%146M+122.1%65.9M
Research & development456M-10.0%506M-12.6%580M+22.1%475M+5.9%448M+48.1%
Selling, general & administrative92.1M-22.6%119M-31.8%174M+7.8%162M+0.6%161M+126.7%
Restructuring—35.0M+158.1%13.6M——
Amortization of intangibles——531K-0.2%532K-0.2%533K-48.8%
Operating income-479M+18.4%-587M+14.2%-684M-182.1%833M+98.0%421M+241.7%
Interest & investment income40.2M-44.0%71.8M-17.5%87.0M+209.7%28.1M—
Other non-operating income-409K+81.6%-2.22M+75.3%-8.99M-311.1%4.26M+145.1%-9.44M-111.3%
Gain (loss) on equity securities1.73M+131.3%-5.53M+74.7%-21.9M+80.3%-111M-180.5%138M
Pre-tax income-438M+16.3%-523M+16.7%-628M-183.3%754M+37.2%550M+284.1%
Income tax217K+119.0%-1.15M+91.2%-13.1M-105.5%238M+1023.8%21.2M+39192.6%
-438M+16.1%-522M+15.1%-615M-219.2%516M-2.4%529M+277.0%
Net income to non-controlling interest0.000.00+100.0%-56.0K0.00—
Net income to common——-615M-219.2%516M-2.4%529M
-$3.16+17.5%-$3.83+16.6%-$4.59-219.8%$3.83-3.3%$3.96+257.8%
EPS (basic)-$3.16+17.5%-$3.83+16.6%-$4.59-218.0%$3.89-4.4%$4.07+262.2%
Weighted-avg shares (basic)139M+1.7%136M+1.6%134M+1.1%133M+2.1%130M+9.0%
Weighted-avg shares (diluted)139M+1.7%136M+1.6%134M-0.5%135M+1.0%133M+12.0%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
514M-50.7%1.04B-34.4%1.59B-37.0%2.52B+61.2%1.56B+102.3%
Cash & equivalents232M+4.1%223M-7.7%242M-71.5%849M+144.0%348M-20.3%
Short-term investments229M-66.3%678M-46.7%1.27B-16.5%1.52B+600.6%217M-27.7%
Cash & short-term investments——1.63B-32.1%2.40B+163.9%910M+23.4%
Accounts receivable———0.00-100.0%773M
Prepaid expenses45.1M-5.4%47.7M-9.2%52.5M-49.6%104M+42.9%73.0M+165.4%
Other current assets—100K-98.7%7.60M-71.2%26.4M—
1.00B-28.3%1.40B-27.1%1.92B-31.5%2.80B+43.4%1.95B+112.7%
Property, plant & equipment55.6M-12.0%63.2M-34.2%96.0M-9.1%106M+146.6%42.8M+138.7%
Operating lease right-of-use62.1M+4.1%59.7M-16.2%71.2M-13.8%82.6M-5.3%87.2M+40.8%
Goodwill16.9M+0.0%16.9M+0.0%16.9M+0.0%16.9M+0.0%16.9M+0.0%
Intangible assets7.85M-3.3%8.12M-64.0%22.6M-31.1%32.8M-1.6%33.3M-1.6%
Long-term investments315M+65.6%190M+80.5%105M+340.0%23.9M-88.1%201M
92.8M-22.4%120M-31.8%175M-65.7%511M+49.8%341M+244.5%
Accounts payable9.80M+92.9%5.08M-19.8%6.33M-1.4%6.42M-1.5%6.52M+28.4%
Deferred revenue0.00-100.0%12.6M-80.5%64.9M+317.9%15.5M-84.2%98.2M+1422.4%
Current lease liability8.80M+13.5%7.75M-39.8%12.9M+211.0%4.14M+5.3%3.93M+8.3%
238M-4.4%248M-24.4%329M-54.6%724M+38.6%522M+158.7%
Deferred revenue (non-current)—0.00-100.0%1.53M-97.1%53.2M+1294.7%3.81M+0.0%
Non-current lease liability89.1M-1.2%90.1M-19.3%112M-9.8%124M-7.3%134M+100.7%
Operating lease liability (total)97.9M-0.0%97.9M-21.4%125M-2.7%128M-6.9%137M+95.9%
Deferred tax liabilities———3.25M-82.4%18.4M+466.8%
Other non-current liabilities21.6M+48.0%14.6M-7.6%15.8M+42.0%11.1M+337.6%2.54M-34.0%
765M-33.5%1.15B-27.7%1.59B-23.5%2.08B+45.1%1.43B+99.7%
Preferred stock0.000.000.000.000.00
Common stock14.0K+0.0%14.0K+7.7%13.0K+0.0%13.0K+0.0%13.0K+0.0%
Additional paid-in capital1.97B+2.8%1.91B+4.5%1.83B+7.0%1.71B+8.8%1.57B+13.4%
Retained earnings-1.20B-57.6%-760M-219.5%-238M-163.0%377M+372.2%-139M+79.2%
Accumulated other comprehensive income-2.06M-19.8%-1.72M-110.7%-815K+91.1%-9.12M-730.0%-1.10M+14.0%
Non-controlling interest
———0.00—
Total equity incl. non-controlling765M-33.5%1.15B-27.7%1.59B-23.5%2.08B+45.1%1.43B+99.7%
Total liabilities & equity1.00B-28.3%1.40B-27.1%1.92B-31.5%2.80B+43.4%1.95B+112.7%
Common shares issued139M+1.8%137M+1.6%135M+1.2%133M+1.6%131M+2.9%
Common shares outstanding139M+1.8%137M+1.6%135M+1.2%133M+1.6%131M+2.9%
Shares outstanding (cover)140M+1.7%137M+1.6%135M+1.1%134M+0.9%132M+3.5%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
-392M+12.2%-446M+42.7%-779M-146.8%1.66B+3595.0%-47.6M+75.1%
Depreciation & amortization11.7M-19.8%14.6M-25.2%19.5M+186.8%6.78M+28.5%5.28M+20.0%
Intangible amortization——531K-0.2%532K-0.2%533K-48.8%
Share-based compensation49.1M-37.5%78.5M-29.5%111M+9.0%102M+21.8%83.8M+203.6%
Deferred income taxes304K+110.3%-2.95M-177.4%-1.06M+93.0%-15.2M-200.0%15.2M+29303.8%
Change in receivables—6.51M+1052.7%565K+100.1%-770M-199.6%773M
Change in payables5.00M+605.8%-988K-235.0%732K-8.2%797K+566.1%-171K+78.4%
Other operating activities—-182K-219.0%153K+139.9%-383K-154.9%697K+2930.4%
310M-37.8%499M+203.3%165M+113.8%-1.19B-747.5%-141M-1327.8%
Capital expenditure4.83M-33.8%7.30M-66.2%21.6M-68.3%68.0M+211.7%21.8M+233.1%
Free cash flow-397M+12.6%-454M+43.3%-800M-150.2%1.60B+2398.4%-69.4M+64.9%
Acquisitions0.000.000.000.000.00
Purchases of investments886M-28.3%1.24B-38.7%2.02B+36.5%1.48B+251.5%420M+4.1%
Sales/maturities of investments1.20B-30.9%1.74B-21.1%2.20B+526.6%352M+16.7%301M-24.8%
Proceeds from sale of PP&E—3.37M0.000.00—
3.79M-13.7%4.39M-41.3%7.48M-78.5%34.8M-65.4%100M-81.1%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.000.000.00-100.0%
Common stock repurchased0.000.000.000.000.00
Dividends paid0.000.000.000.000.00
Other financing activities-361K-118.8%-165K+42.5%-287K-10.4%-260K—
Net change in cash-77.6M-235.2%57.4M+109.5%-607M-220.2%505M+672.9%-88.1M-126.8%
Income taxes paid2.42M+207.9%786K-70.6%2.68M+101.1%-252M0.00
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap841M-16.4%1.01B-25.6%1.35B-59.8%3.37B-39.2%5.54B+61.8%
P/E———2.9×-71.9%10.5×
P/S12.3×-9.5%13.6×+19.1%11.4×+704.4%1.4×-72.0%5.1×-88.7%
P/B1.1×+25.6%0.9×+8.3%0.8×-48.4%1.6×-59.5%3.9×-19.0%
P/FCF
———2.1×—
Earnings yield———33.9%+255.4%9.5%
FCF yield
———46.5%—
Source filing10-K10-K10-K10-K10-K

About this data

Source: VIR’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all VIR filings on SEC EDGAR → Not investment advice.